Restarting at your full maintenance dose risks severe nausea and gastrointestinal distress
Tracking symptoms by day-after-dose instead of as isolated events makes patterns easier to spot
The incidence rates of inpatient hypoglycemic events and all-cause mortality were 0.8 and 1.7 per 100 person-years, respectively
Reporte Ias reacciones adversas aI correo: [email protected] Titular del Registro: Novo Nordisk A/S Novo All Bagsvaerd 2880, Dinamarca Representante Legal: NOVO NORDISK MXICO, S.A
The primary endpoint of cardiovascular death or worsening heart failure events occurred in 36 patients in the tirzepatide group compared with 56 patients in the placebo group, (hazard ratio, 0.62
These symptoms are different from mild irritation because they tend to intensify, expand, or come with whole-body symptoms